Skip to main content
. 2020 Jan 31;11:93. doi: 10.3389/fimmu.2020.00093

Figure 7.

Figure 7

Protective effect of hBD2 in T cell transfer colitis. Colitis was induced by transferring CD4+/CD25 T cells from WT mice to SCID mice. Development of colitis was observed for 94 days. Daily treatment with hBD2 (0.1 mg/kg or 1 mg/kg, s.c.) and Dexamethasone (0.3 mg/kg, i.p.) started 7 days after the transfer. (A) Weight change of mice during the experiment was monitored as well as (B) development of clinical symptoms as DAI. (C) Alteration of stool consistency was assessed as stool score. At the end of the experiment (D) colon weight was measured and (E) activity of myeloperoxidase (MPO) was quantified. (F) Representative images from the colon of differentially treated mice are shown. Results are presented as mean ± SEM, n = 6 (sham treated animals), n = 10 (vehicle and dexamethasone mice) and n = 11 (hBD2 mice). Appropriate statistical comparisons are shown within the graph by a Kruskal-Wallis-test for non-parametric data with a Dunn's post-test.